Paul Lambert

Bio:

Paul Lambert is CEO of EMED Technologies Corporation, a global drug delivery and home healthcare company specializing in infusion and drug delivery systems for subcutaneous therapies. He has led EMED as CEO since 1999, with responsibility for global strategy, operations, product development, manufacturing, commercialization, and international partnerships.

With more than three decades of experience in medical technology, Mr. Lambert has led the development and commercialization of drug delivery platforms supporting home-based care, with a focus on patient comfort, quality of care, and patient independence. His experience spans clinical requirements, product strategy, engineering, manufacturing, supply chain, and commercial operations across multiple global regions.

Mr. Lambert has led the negotiation and execution of strategic manufacturing, supply, and distribution agreements with leading global medical technology companies, including 3M, B. Braun, CSL, Takeda, Kimberly-Clark, and Teleflex. He has also overseen the expansion of the company's infrastructure and capabilities, while building and managing commercial and technology partnerships across North America, Europe, and Asia. His experience spans strategic growth, global operations, business development, and the management of complex partnerships within the medical technology industry.

Mr. Lambert has led the development of multiple drug delivery platforms from concept through commercialization, working with pharmaceutical and medical technology partners to translate clinical and patient needs into scalable solutions for home healthcare.

Mr. Lambert holds an MSc in Bioengineering and Biomedical Engineering from Case Western Reserve University, with graduate research focused on neural prostheses and respiratory closed-loop systems.